In yesterday’s article, I reviewed the immensely concerning data that emerged throughout the SSRI antidepressant trials. Sadly, rather than this data being listened to, it was given a pass by the FDA, a pattern we have tragically seen occur with numerous highly lucrative pharmaceuticals. In my eyes, three things stand out about the SSRI saga.… Read More »
Critical to the wellbeing of pregnant women and their infants is universal screening for drug and alcohol use. This is an essential first step in identifying women with harmful substance use and connecting them with appropriate services. Screening, Brief Intervention and Referral to Treatment or SBIRT has been shown to be a quick and effective… Read More »
Dive Brief: The Supreme Court has agreed to hear a case involving the Trump administration’s cuts of Medicare Part B reimbursement for drugs that hospitals obtain under the 340B program. The case pivots on whether CMS has the authority to make payment cuts under the outpatient prospective payment system. The justices are expected to hear… Read More »
FRIDAY, March 5, 2021 (HealthDay News) — Seizures of illegal drugs fell sharply in the United States during early COVID-19 lockdowns, but spiked once stay-at-home orders eased. Researchers studied seizures of marijuana, cocaine, methamphetamine, heroin and fentanyl in five locations between March 2019 (a year before the pandemic began in the United States) through September… Read More »
Dive Brief: The Food and Drug Administration has granted a full approval to Gilead’s COVID-19 drug Veklury, making it the first medicine to win a standard clearance from the agency to treat the disease caused by the new coronavirus. The FDA authorized Veklury for emergency use in May, a declaration that’s only valid during a… Read More »